Get started
Author

Mahsa Abassi

Observed name: M Abassi
Observed institutions: University of Minnesota, University of Minnesota System, Infectious Diseases Institute, Research Institute of the McGill University Health Centre, McGill University, Makerere University
ORCID: 0000-0001-9601-3006
Observed ORCID: 0000-0001-9601-3006
OpenAlex ID: A5014392945
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
2020 · David R. Boulware, Matthew F. Pullen, et al. · New England Journal of Medicine · 1,318
PDF
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
2020 · Caleb P. Skipper, Katelyn A. Pastick, et al. · Annals of Internal Medicine · 539
PDF
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
2020 · Katelyn A Pastick, Elizabeth C Okafor, et al. · Open Forum Infectious Diseases · 201
PDF
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda
2015 · Kyle D. Smith, Beatrice Achan, et al. · Antimicrobial Agents and Chemotherapy · 191
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
2016 · Joshua Rhein, Bozena M Morawski, et al. · The Lancet Infectious Diseases · 183
Cryptococcal Meningitis: Diagnosis and Management Update
2015 · Mahsa Abassi, David R. Boulware, et al. · Current Tropical Medicine Reports · 174
PDF
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
2020 · Radha Rajasingham, Ananta S Bangdiwala, et al. · Clinical Infectious Diseases · 140
PDF
Cryptococcal meningitis
2023 · Lillian Tugume, Kenneth Ssebambulidde, et al. · Nature Reviews Disease Primers · 125
PDF
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda
2016 · Mahsa Abassi, Bozena M. Morawski, et al. · Journal of NeuroVirology · 74
PDF
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
2023 · David R Boulware, Mucunguzi Atukunda, et al. · Clinical Infectious Diseases · 71
PDF
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation
2018 · Joshua Rhein, Kathy H Hullsiek, et al. · Open Forum Infectious Diseases · 61
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
2020 · Caleb P. Skipper, Mucunguzi Atukunda, et al. · Antimicrobial Agents and Chemotherapy · 59
HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts
2018 · Lillian Tugume, Joshua Rhein, et al. · The Journal of Infectious Diseases · 58
PDF
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
2020 · Sarah M Lofgren, Melanie R Nicol, et al. · Open Forum Infectious Diseases · 56
PDF
Symptoms of COVID-19 Outpatients in the United States
2020 · Matthew F Pullen, Caleb P Skipper, et al. · Open Forum Infectious Diseases · 55
PDF
Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults
2019 · Caleb Skipper, Mahsa Abassi, et al. · Journal of Fungi · 47
PDF
Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis
2018 · Kenneth Ssebambulidde, Ananta S Bangdiwala, et al. · Clinical Infectious Diseases · 47
PDF
Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
2017 · Edward Mpoza, Joshua Rhein, et al. · Medical Mycology Case Reports · 40
PDF
Diagnosis and management of cryptococcal meningitis in HIV-infected adults
2023 · Thomas C. McHale, David R. Boulware, et al. · Clinical Microbiology Reviews · 39
PDF
Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis
2017 · Sarah Lofgren, Kathy H. Hullsiek, et al. · The Journal of Infectious Diseases · 32
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
2019 · Supavit Chesdachai, Radha Rajasingham, et al. · Open Forum Infectious Diseases · 30
PDF
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials
2020 · Matthew F Pullen, Katherine Huppler Hullsiek, et al. · Clinical Infectious Diseases · 28
PDF
Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis
2016 · L Tugume, BM Morawski, et al. · HIV Medicine · 28
Works count: 70
Citation count: 4,013
H-index: 26
I10-index: 41
Year
Topic
Type